Vaishali Pharma Limited — Board Meeting, 06-02-2025: Outcome of Board Meeting

Vaishali Pharma Limited has announced a board meeting to review and approve the unaudited financial results for the quarter and nine months ended December 31, 2024. The results show total income of ₹2,898.20 Cr, with a profit before tax of ₹192.75 Cr. The company continues to focus on its sole segment, the sale of pharmaceutical products, with no separate reportable segments identified. The board spurred operations with these results, reflecting positive growth in revenues compared to the previous quarters.